Vessel-specific toll-like receptor profiles in human medium and large arteries

Circulation

Volumn 118, Issue 12, 2008, Pages 1276-1284

  Pryshchep, Olga ^a   Ma Krupa, Wei ^a   Younge, Brian R ^b   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Arteries; Immune system; Inflammation

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; LYMPHOTOXIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; AORTA; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; ILIAC ARTERY; INNATE IMMUNITY; MESENTERIC ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEVERE COMBINED IMMUNODEFICIENCY; SUBCLAVIAN ARTERY; T LYMPHOCYTE; TEMPORAL ARTERY; ARTERY; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; HISTOLOGY; MALE; METHODOLOGY; MIDDLE AGED; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

ARTERIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; TOLL-LIKE RECEPTORS;

EID: 53449092909     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.789172     Document Type: Article

References (37)

1. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res. 1967;20:409-421.
2. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol. 1952;22:777-790.
3. Morgan MD, Savage CO. Vasculitis in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2005;19:215-233.
4. Burke AP, Tavora F, Narula N, Tomaszewski JE, Virmani R. Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification. Hum Pathol. 2008;39:514-526.
5. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160-169.
6. Hoffman GS. Large-vessel vasculitis: unresolved issues. Arthritis Rheum. 2003;48:2406-2414.
7. Mandell BF, Hoffman GS. Differentiating the vasculitides. Rheum Dis Clin North Am. 1994;20:409-442.
8. Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascul Pharmacol. 2007;46:229-237.
9. Trepels T, Zeiher AM, Fichtischerer S. The endothelium and inflammation. Endothelium. 2006;13:423-429.
10. Bacon PA. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol. 2005;17:49-55.
11. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-3561.
12. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol. 2004;4:360-370.
13. Steeber DA, Tedder TF. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res. 2000;22:299-317.
14. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest. 2001;107:R15-R22.
15. Hildebrandt HA, Goessl M, Mannheim D, Versari D, Herrmann J, Spendlove D, Bajanowski T, Malyar NM, Erbel R, Lerman LO, Lerman A. Differential distribution of vasa vasorum in different vascular beds in humans. Atherosclerosis. 2008;199:47-54.
16. Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol. 1996;148:1925-1933.
17. Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci. 2005;1062:195-208.
18. Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2004;199:173-183.
19. De Meyer GR, Van Put DJ, Kockx MM, Van Schil P, Bosmans R, Bult H, Buyssens N, Vanmaele R, Herman AG. Possible mechanisms of collar-induced intimal thickening. Arterioscler Thromb Vasc Biol. 1997; 17:1924-1930.
20. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-{alpha} and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation. 2007;116:2043-2052.
21. Doherty TM, Fisher EA, Arditi M. TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis. Trends Immunol. 2006;27:222-227.
22. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med. 2006;203:239-250.
23. Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res. 1995;29:689-696.
24. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, Romani N, Wick G. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol. 2001;21:503-508.
25. Millonig G, Schwentner C, Mueller P, Mayerl C, Wick G. The vascular-associated lymphoid tissue: a new site of local immunity. Curr Opin Lipidol. 2001;12:547-553.
26. Sanoudou D, Kang PB, Haslett JN, Han M, Kunkel LM, Beggs AH. Transcriptional profile of postmortem skeletal muscle. Physiol Genomics. 2004;16:222-228.
27. + T cells in rheumatoid arthritis. Arthritis Rheum. 2005;52:3839-3849.
28. Hoffman GS. Determinants of vessel targeting in vasculitis. Ann N Y Acad Sci. 2005;1051:332-339.
29. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol. 1992;10:561-591.
30. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G, Xu Q. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 1997;11:1199-1207.
31. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med. 2006;6:457-477.
32. Moulton KS. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol. 2006;17:548-555.
33. Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007;102:123-132.
34. Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation. 2006;114:2482-2489.
35. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158-1161.
36. Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant cell arteritis. Clin Immunol. 2005;115:38-46.
37. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911-920.